Advantage Trust Company’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$49.7K Sell
548
-150
-21% -$13.7K 0.02% 107
2026
Q1
$71.7K Hold
698
0.03% 69
2025
Q4
$87.5K Sell
698
-150
-18% -$19.1K 0.04% 63
2025
Q3
$114K Sell
848
-56
-6% -$7.35K 0.05% 80
2025
Q2
$123K Hold
904
0.06% 77
2025
Q1
$120K Hold
904
0.07% 60
2024
Q4
$102K Sell
904
-150
-14% -$17.3K 0.06% 71
2024
Q3
$120K Sell
1,054
-252
-19% -$27.6K 0.08% 60
2024
Q2
$136K Hold
1,306
0.1% 56
2024
Q1
$148K Hold
1,306
0.11% 57
2023
Q4
$144K Buy
+1,306
New +$130K 0.11% 53

Other funds holding ABT

Advantage Trust Company's ABT Position: Q2 2026 in Review

Advantage Trust Company reduced its Abbott (ABT) stake by 21% in Q2 2026, selling an estimated $13.7K and leaving 548 shares worth $49.7K. The position accounts for 0.02% of the portfolio, ranked #107.

Advantage Trust Company first reported a position in ABT in Q4 2023 and has held it in 11 quarters since. The position peaked at $148K in Q1 2024. 1,014 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Advantage Trust Company held 548 shares of Abbott worth $49.7K as of Q2 2026.
  • Advantage Trust Company sold 150 Abbott shares in Q2 2026, an estimated $13.7K.
  • Abbott made up 0.02% of Advantage Trust Company's portfolio in Q2 2026, its #107 holding.
  • Advantage Trust Company first reported a position in Abbott in Q4 2023 and has held it in 11 quarters since.
  • Advantage Trust Company's Abbott position peaked at $148K in Q1 2024.
  • 1,014 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Advantage Trust Company's 13F filing for Q2 2026, filed 17 Jul 2026.